IDH1 and central nervous system cancer: Additionally, detection of 2-hydroxyglutarate (2-HG) with MR-spectroscopy (MRS) was a strong predictor of IDH-mutations in glioblastoma (grade IV) [29], grade II-III glioma [30] and grade II-III-IV glioma [31].